← All trials
NCT07172724
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2025
- Primary completion
- Mar 31, 2026
- Completion date
- Jun 30, 2027
- First posted
- Sep 15, 2025
- Last posted
- Sep 15, 2025
- Enrollment
- 48
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Federal University of Minas GeraisLead sponsor
- Fundação de Amparo à Pesquisa do Estado de São PauloCollaborator
- Federal University of Minas GeraisSponsor investigator
- University of Sao PauloCollaborator
- Government of BrazilCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.